Parsons James T.
SEC CIK 1759855 · EDGAR
BoughtSold
Most active insiders at ONCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Seizinger Bernd R. | Dir | $187.8K | — |
| 2 | Kelly Jared | CEO, Dir | $34.3K | — |
| 3 | Andrews Patricia S | Dir | $30.4K | — |
| 4 | Aromando Andrew | Chief Business Off | $25.5K | — |
| 5 | Pisano Wayne | Dir | $25.2K | — |
| 6 | Brown Deborah Margaret | Dir | $21.2K | — |
| 7 | Parsons James T. | Dir | $10.3K | — |
| 8 | Look Kirk | CFO | $10.1K | — |
| 9 | Heineman Thomas Charles | Chief Medical Off | $10.1K | — |
| 10 | Hagerman Allison | VP, Product Development | $8,300 | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | 2026-03-11 | ONCY | ONCOLYTICS BIOTECH INC | Parsons James T. | Dir | P - Purchase | $1.03 | +10.0K | 41.8K | +31% | +$10.3K | |
| 2026-01-06 | 2026-01-02 | DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Dir | A - Grant | $8.42 | +10.1K | 97.9K | +11% | +$85.0K | |
| D | 2025-11-25 | 2025-11-21 | DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Dir | M - OptEx | $2.20 | +12.0K | 87.9K | +16% | +$26.4K |
| D | 2025-01-03 | 2025-01-02 | DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Dir | A - Grant | $5.34 | +15.9K | 75.9K | +27% | +$85.0K |
| 2024-01-02 | 2024-01-02 | DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Dir | A - Grant | $2.80 | +21.4K | 59.9K | +56% | +$60.0K | |
| 2022-01-03 | 2022-01-03 | DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Dir | A - Grant | $3.58 | +16.8K | 38.5K | +77% | +$60.0K |
Purchase Sale Sale after option exercise All abbreviations